CPSE:ZEALBiotechs
Zealand Pharma (CPSE:ZEAL) Reports Weaker Earnings, Is It Still Below Fair Value?
Zealand Pharma (CPSE:ZEAL) is back in focus after its second quarter 2026 earnings, which showed lower sales and net income compared with the same periods in 2025 and prompted investors to reassess the stock.
At a share price of DKK317.0, Zealand Pharma has seen modest recent momentum, with a 1 month share price return of 3.63% and a small gain over 7 days. The year to date share price return is down 31.10% and the 1 year total shareholder return is down 28.18%. However, the 3 and 5 year...